Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Effects of alpha- and beta-interferon on oxidative burst responses of monocytes and monocyte-derived macrophages from patients with HIV infection.

J Biol Regul Homeost Agents. 1990 Jul-Sep;4(3):93-7. Unique Identifier : AIDSLINE MED/92238343
Muller F; Rollag H; Froland SS; Kaptein Wilhelmsen og Frues Institute of Bacteriology, University; of Oslo, Rikshospitalet, Norway.


Abstract: In the present paper, we have studied the effects of interferon (IFN) -alpha and IFN-beta on the oxidative burst (OB) responses in monocytes and monocyte-derived macrophages from patients with a relatively early phase of HIV infection. We found that in monocytes from patients with HIV infection, the defective OB response could be partially restored by pretreatment with IFN-beta when the cells were challenged with zymosan. No such stimulatory effect was seen in the control groups. In monocyte-derived macrophages, both IFN-alpha and IFN-beta stimulated the phorbol myristate acetate (PMA) induced OB response in the patient group as well as in the blood donor control group. Generation of an OB is an important part of the antimicrobial defence of mononuclear phagocytes. The positive effects of IFN on the OB responses of monocytes and macrophages from patients with HIV infection may be of importance when IFNs are considered in the treatment of HIV-related disease.
Keywords: Cells, Cultured Female Human HIV Infections/*BLOOD Interferon Type I/*PHARMACOLOGY Interferon-beta/*PHARMACOLOGY Macrophages/*DRUG EFFECTS/METABOLISM Male Monocytes/*DRUG EFFECTS/METABOLISM Nitroblue Tetrazolium/METABOLISM Respiratory Burst/*DRUG EFFECTS Support, Non-U.S. Gov't Tetradecanoylphorbol Acetate/PHARMACOLOGY JOURNAL ARTICLEKWDcells,culturedfemalehumanhivinfections/KWDbloodinterferontypei/KWDpharmacologyinterferon-beta/KWDpharmacologymacrophages/KWDdrugeffects/metabolismmalemonocytes/KWDdrugeffects/metabolismnitrobluetetrazolium/metabolismrespiratoryburst/KWDdrugeffectssupport,non-uKWDsKWDgov'ttetradecanoylphorbolacetate/pharmacologyjournalarticle
920730
M9271072

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .